Lv2
196 积分 2024-06-27 加入
Exploring nondegrading molecular glues for protein–protein interactions
18天前
已完结
2025 FDA approvals
3个月前
已完结
Phage-derived anti-idiotype and anti-YTE antibodies in development of MK-1654 pharmacokinetic and immune response assays
6个月前
已完结
Population Pharmacokinetics and Pharmacodynamics of Crizanlizumab in Healthy Subjects and Patients with Sickle Cell Disease
7个月前
已完结
皖公网安备34019202002308
